The Role of D2-like Dopaminergic Receptor in Dopamine-mediated Modulation of Th17-cells in Multiple Sclerosis

Background: Dopamine is one of the main mediators capable regulate the neuroimmune interaction and is involved in multiple sclerosis (MS) pathogenesis. Objective: The aim of this study was to clarify the role of dopamine and its receptors in modulation of Th17-cells in MS. Methods: 34 relapsing-remitting MS patients and 23 healthy subjects were examined. To assess the effect of dopamine on Th17-cells, CD4(+) T-cells were cultured in the presence of dopamine and antagonist or agonist of D-1- or D-2-like dopaminergic receptors and stimulated with anti-CD3/CD28-microbeads. The levels of cytokines in supernatants were assessed by ELISA. Results: Production of interleukin-17 (IL-17), interferon-gamma (IFN-gamma), granulocyte-colony stimulating factor (GM-CSF), and IL-21 by CD4(+) T-cells as well as dopamine were comparable between the groups. Dopamine suppressed cytokine secretion by activated CD4(+) T-cells in both groups. Blockade of D-1-like dopaminergic receptor with a specific antagonist SCH23390 did not affect dopamine-mediated cytokine suppression. In contrast, blockade of D-2-like dopaminergic receptor by sulpiride decreased dopamine's inhibitory effect on IL-17 secretion in both groups and GM-CSF and IL-21 production in MS patients. Blockade of D-1-like dopaminergic receptor directly inhibited IL-17, IFN-gamma, GM-CSF in both groups and IL-21 production in healthy subjects, while blockade of D-2-like dopaminergic receptor had no effect on cytokine secretion. Finally, activation of D-2-like dopaminergic receptor with a specific agonist quinpirole decreased cytokine production in both groups. Conclusion: These data suggest an inhibitory role of dopamine on Th17-cells in MS, which could be mediated by the activation of the D-2-like dopaminergic receptor.

Automated summary

Dopamine inhibits the function of Th17 cells in multiple sclerosis (MS) through the activation of D-2-like dopaminergic receptor.